vs
MANNKIND CORP（MNKD）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是MANNKIND CORP的1.3倍（$151.1M vs $112.0M），MANNKIND CORP同比增速更快（45.8% vs 3.6%），STURM RUGER & CO INC自由现金流更多（$12.3M vs $-10.0M），过去两年MANNKIND CORP的营收复合增速更高（30.0% vs 5.1%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
MNKD vs RGR — 直观对比
营收规模更大
RGR
是对方的1.3倍
$112.0M
营收增速更快
MNKD
高出42.2%
3.6%
自由现金流更多
RGR
多$22.3M
$-10.0M
两年增速更快
MNKD
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $151.1M |
| 净利润 | $-15.9M | — |
| 毛利率 | 87.6% | 17.8% |
| 营业利润率 | -6.9% | 2.3% |
| 净利率 | -14.2% | — |
| 营收同比 | 45.8% | 3.6% |
| 净利润同比 | -314.9% | — |
| 每股收益（稀释后） | $-0.05 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRGR
| Q4 25 | $112.0M | $151.1M | ||
| Q3 25 | $82.1M | $126.8M | ||
| Q2 25 | $76.5M | $132.5M | ||
| Q1 25 | $78.4M | $135.7M | ||
| Q4 24 | $76.8M | $145.8M | ||
| Q3 24 | $70.1M | $122.3M | ||
| Q2 24 | $72.4M | $130.8M | ||
| Q1 24 | $66.3M | $136.8M |
净利润MNKDRGR
| Q4 25 | $-15.9M | — | ||
| Q3 25 | $8.0M | $1.6M | ||
| Q2 25 | $668.0K | $-17.2M | ||
| Q1 25 | $13.2M | $7.8M | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $11.6M | $4.7M | ||
| Q2 24 | $-2.0M | $8.3M | ||
| Q1 24 | $10.6M | $7.1M |
毛利率MNKDRGR
| Q4 25 | 87.6% | 17.8% | ||
| Q3 25 | 94.5% | 15.1% | ||
| Q2 25 | 94.0% | 3.9% | ||
| Q1 25 | 95.2% | 22.0% | ||
| Q4 24 | 93.7% | 22.8% | ||
| Q3 24 | 95.4% | 18.5% | ||
| Q2 24 | 92.3% | 22.3% | ||
| Q1 24 | 94.2% | 21.5% |
营业利润率MNKDRGR
| Q4 25 | -6.9% | 2.3% | ||
| Q3 25 | 23.0% | -2.7% | ||
| Q2 25 | 6.9% | -15.6% | ||
| Q1 25 | 28.5% | 6.2% | ||
| Q4 24 | 34.5% | 7.8% | ||
| Q3 24 | 18.2% | 3.1% | ||
| Q2 24 | 22.9% | 6.9% | ||
| Q1 24 | 25.2% | 5.5% |
净利率MNKDRGR
| Q4 25 | -14.2% | — | ||
| Q3 25 | 9.7% | 1.2% | ||
| Q2 25 | 0.9% | -13.0% | ||
| Q1 25 | 16.8% | 5.7% | ||
| Q4 24 | 9.7% | — | ||
| Q3 24 | 16.5% | 3.9% | ||
| Q2 24 | -2.8% | 6.3% | ||
| Q1 24 | 16.0% | 5.2% |
每股收益（稀释后）MNKDRGR
| Q4 25 | $-0.05 | $0.22 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $0.00 | $-1.05 | ||
| Q1 25 | $0.04 | $0.46 | ||
| Q4 24 | $0.03 | $0.62 | ||
| Q3 24 | $0.04 | $0.28 | ||
| Q2 24 | $-0.01 | $0.47 | ||
| Q1 24 | $0.04 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $92.5M |
| 总债务越低越好 | $354.6M | — |
| 股东权益账面价值 | $-51.0M | $283.8M |
| 总资产 | $792.2M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MNKDRGR
| Q4 25 | $171.3M | $92.5M | ||
| Q3 25 | $260.0M | $80.8M | ||
| Q2 25 | $179.0M | $101.4M | ||
| Q1 25 | $181.5M | $108.3M | ||
| Q4 24 | $197.3M | $105.5M | ||
| Q3 24 | $251.6M | $96.0M | ||
| Q2 24 | $247.8M | $105.6M | ||
| Q1 24 | $300.7M | $115.3M |
总债务MNKDRGR
| Q4 25 | $354.6M | — | ||
| Q3 25 | $109.7M | — | ||
| Q2 25 | $36.2M | — | ||
| Q1 25 | $36.1M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $227.9M | — | ||
| Q2 24 | $227.6M | — | ||
| Q1 24 | $264.1M | — |
股东权益MNKDRGR
| Q4 25 | $-51.0M | $283.8M | ||
| Q3 25 | $-44.6M | $279.6M | ||
| Q2 25 | $-55.0M | $289.3M | ||
| Q1 25 | $-58.6M | $321.5M | ||
| Q4 24 | $-78.8M | $319.6M | ||
| Q3 24 | $-209.9M | $314.9M | ||
| Q2 24 | $-225.8M | $321.5M | ||
| Q1 24 | $-230.0M | $332.0M |
总资产MNKDRGR
| Q4 25 | $792.2M | $342.0M | ||
| Q3 25 | $494.6M | $342.3M | ||
| Q2 25 | $411.7M | $349.5M | ||
| Q1 25 | $410.1M | $379.0M | ||
| Q4 24 | $393.8M | $384.0M | ||
| Q3 24 | $464.2M | $373.5M | ||
| Q2 24 | $443.8M | $376.7M | ||
| Q1 24 | $480.9M | $385.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $12.3M |
| 自由现金流率自由现金流/营收 | -8.9% | 8.2% |
| 资本支出强度资本支出/营收 | 1.8% | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.7M | $38.5M |
8季度趋势，按日历期对齐
经营现金流MNKDRGR
| Q4 25 | $-8.0M | $15.5M | ||
| Q3 25 | $23.6M | $12.9M | ||
| Q2 25 | $8.9M | $14.7M | ||
| Q1 25 | $-6.4M | $11.1M | ||
| Q4 24 | $22.6M | $20.0M | ||
| Q3 24 | $9.3M | $9.4M | ||
| Q2 24 | $3.8M | $18.7M | ||
| Q1 24 | $6.7M | $7.3M |
自由现金流MNKDRGR
| Q4 25 | $-10.0M | $12.3M | ||
| Q3 25 | $22.5M | $7.0M | ||
| Q2 25 | $7.8M | $9.1M | ||
| Q1 25 | $-6.7M | $10.0M | ||
| Q4 24 | $19.7M | $16.4M | ||
| Q3 24 | $7.9M | $2.6M | ||
| Q2 24 | $861.0K | $10.1M | ||
| Q1 24 | $4.3M | $5.6M |
自由现金流率MNKDRGR
| Q4 25 | -8.9% | 8.2% | ||
| Q3 25 | 27.4% | 5.5% | ||
| Q2 25 | 10.2% | 6.9% | ||
| Q1 25 | -8.6% | 7.4% | ||
| Q4 24 | 25.7% | 11.2% | ||
| Q3 24 | 11.3% | 2.1% | ||
| Q2 24 | 1.2% | 7.7% | ||
| Q1 24 | 6.5% | 4.1% |
资本支出强度MNKDRGR
| Q4 25 | 1.8% | 2.1% | ||
| Q3 25 | 1.4% | 4.6% | ||
| Q2 25 | 1.5% | 4.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 3.8% | 2.5% | ||
| Q3 24 | 2.0% | 5.5% | ||
| Q2 24 | 4.1% | 6.6% | ||
| Q1 24 | 3.6% | 1.3% |
现金转化率MNKDRGR
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | 8.15× | ||
| Q2 25 | 13.40× | — | ||
| Q1 25 | -0.48× | 1.43× | ||
| Q4 24 | 3.05× | — | ||
| Q3 24 | 0.81× | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | 0.63× | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
